These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1775727)

  • 1. Muscarinic M2 receptors in rat brain labeled with [3H] AF-DX 384.
    Castoldi AF; Fitzgerald B; Manzo L; Tonini M; Costa LG
    Res Commun Chem Pathol Pharmacol; 1991 Dec; 74(3):371-4. PubMed ID: 1775727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of [3H]AF-DX 384 to rat ileal smooth muscle muscarinic receptors.
    Entzeroth M; Mayer N
    J Recept Res; 1991; 11(1-4):141-52. PubMed ID: 1886077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic characterization of muscarinic receptors of insect brains.
    Abdallah EA; Eldefrawi ME; Eldefrawi AT
    Arch Insect Biochem Physiol; 1991; 17(2-3):107-18. PubMed ID: 1802028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of muscarinic receptors in the uterus of oestrogen-primed and pregnant rats.
    Munns M; Pennefather JN
    Br J Pharmacol; 1998 Apr; 123(8):1639-44. PubMed ID: 9605571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain.
    Aubert I; Cécyre D; Gauthier S; Quirion R
    Eur J Pharmacol; 1992 Jul; 217(2-3):173-84. PubMed ID: 1425938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AF-DX 384 binding in rabbit cingulate cortex: two site kinetics and section autoradiography.
    Dopke KL; Vrana KE; Vogt LJ; Vogt BA
    J Pharmacol Exp Ther; 1995 Jul; 274(1):562-9. PubMed ID: 7616446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of [3H]AF-DX 384 to cloned and native muscarinic receptors.
    Miller JH; Gibson VA; McKinney M
    J Pharmacol Exp Ther; 1991 Nov; 259(2):601-7. PubMed ID: 1941609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous binding of [3H]4-DAMP to muscarinic cholinergic sites in the rat brain: evidence from membrane binding and autoradiographic studies.
    Araujo DM; Lapchak PA; Quirion R
    Synapse; 1991 Nov; 9(3):165-76. PubMed ID: 1776129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
    Mei L; Lai J; Roeske WR; Fraser CM; Venter JC; Yamamura HI
    J Pharmacol Exp Ther; 1989 Feb; 248(2):661-70. PubMed ID: 2537406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.
    Tränkle C; Andresen I; Lambrecht G; Mohr K
    Mol Pharmacol; 1998 Feb; 53(2):304-12. PubMed ID: 9463489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
    Tonnaer JA; Ernste BH; Wester J; Kelder K
    J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of [3H]AF-DX 116 binding sites in the rat brain: evidence for heterogeneity of muscarinic-M2 receptor sites.
    Araujo DM; Lapchak PA; Regenold W; Quirion R
    Synapse; 1989; 4(2):106-14. PubMed ID: 2781463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB; Eubanks JH; Creese I
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.